SIPI-7623
N/A
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameSIPI-7623
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesNanjing Ke Feiping Medical Technology Co LtdState Pharmaceutical Administration of Shanghai Institute of Pharmaceutical Industry
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesN/A
Inactive CompaniesState Pharmaceutical Administration of Shanghai Institute of Pharmaceutical IndustryNanjing Ke Feiping Medical Technology Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A